2013
DOI: 10.2144/000114115
|View full text |Cite
|
Sign up to set email alerts
|

An Assay for Small Scale Screening of Candidate β Cell Proliferative Factors Using Intact Islets

Abstract: Current protocols for screening proliferative factors for β cells ex vivo are time-consuming, require cell lines or dissociated islets, and often entail expensive specialized screening equipment. Here we present an efficient and lower cost alternative that utilizes intact mouse islets for the initial screening of proliferative compounds and allows confirmation of β cell proliferation from the same islets. This protocol simplifies the process, saves money, and provides a way to identify β cell proliferative fac… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
11
0

Year Published

2014
2014
2021
2021

Publication Types

Select...
7

Relationship

5
2

Authors

Journals

citations
Cited by 8 publications
(12 citation statements)
references
References 12 publications
1
11
0
Order By: Relevance
“…To investigate this, β-cell proliferation was measured in young (8–10 weeks old) WT mouse islets treated ex vivo with the EP3 agonist sulprostone, the EP3 antagonist DG-041, the EP4 agonist CAY10598, or the EP4 antagonist L-161,982 using a proliferation assay developed by our laboratory [38]. After four days of treatment, PL increased β-cell proliferation 3–4-fold over vehicle-treated islets (Figure 2 A - B ).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…To investigate this, β-cell proliferation was measured in young (8–10 weeks old) WT mouse islets treated ex vivo with the EP3 agonist sulprostone, the EP3 antagonist DG-041, the EP4 agonist CAY10598, or the EP4 antagonist L-161,982 using a proliferation assay developed by our laboratory [38]. After four days of treatment, PL increased β-cell proliferation 3–4-fold over vehicle-treated islets (Figure 2 A - B ).…”
Section: Resultsmentioning
confidence: 99%
“…Ex vivo mouse β-cell proliferation was performed as previously described [38] , [39] . Briefly, 40 mouse islets per replicate were cultured for four days in mouse proliferation media in the presence of 0.1 mM EGTA, which mildly loosens cell–cell contacts to enhance nutrient and compound accessibility to the core of the islet [38] and one or more of the following compounds: vehicle (phosphate buffered saline (PBS)), 0.5 μg/mL recombinant human placental lactogen (PL; Harbor-UCLA Research and Education Institute), 30 nM sulprostone (Cayman Chemical), 30 nM DG-041 (Vanderbilt Institute of Chemical Biology Synthesis Core [40] ), 10 nM CAY10598 (Cayman Chemical), 100 nM L-161,982 (Cayman Chemical), 1 μM U-73122 (Sigma), or 30 nM rapamycin (Calbiochem). All compounds were diluted in PBS to obtain desired concentrations.…”
Section: Methodsmentioning
confidence: 99%
“…First, a blinded, small-scale ex vivo assay was performed on intact islets isolated from WT mice as previously described47. Compounds were initially screened at multiple concentrations (0.1–5 mM) to assess dose-response.…”
Section: Methodsmentioning
confidence: 99%
“…Islets were treated with vehicle or recombinant human CTGF ( 22 ). β-Cell proliferation was assayed as in Mosser and Gannon ( 23 ), with a minimum of 2,500 cells quantified per animal.…”
Section: Methodsmentioning
confidence: 99%